Relmada discontinues late-stage trials for depression drug, explores sale

Relmada Therapeutics

09/12/2024 12:39

Dec 9 (Reuters) - Relmada Therapeutics  RLMD.O  said on
Monday it would discontinue the two late-stage studies planned
for the development of its depression drug and explore strategic
alternatives including a sale. 

 (Reporting by Christy Santhosh in Bengaluru; Editing by Sriraj
Kalluvila)
 ((Christy.Santhosh@thomsonreuters.com;))